Atlas Trials

Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy

Clinical trial NCT01153672 · COMPLETED

Trial details

NCT number
NCT01153672
Sponsor
University of Washington
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Male Breast CancerRecurrent Breast CancerStage IV Breast Cancer
Start date
2010-11-01
Primary completion
2012-07-01
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.